https://www.taxtmi.com/notifications?id=140236 Exempts specified pharmaceutical goods from state tax in excess of the rates specified in the notification, referencing tariff items in the First Schedule to the Customs Tariff Act; Tocilizumab and Amphotericin B are subject to nil state tax, while Remdesivir, Heparin, Itolizumab, Posaconazole, Infliximab, Bamlanivimab & Etesevimab, Casirivimab & Imdevimab, 2 Deoxy D Glucose and Favipiravir are subject to a reduced state tax rate; the exemption operates for the temporary period from October through December 2021. en-us Sat, 05 Mar 2022 00:00:00 +0530 Wed, 31 May 2023 18:48:00 +0530 TaxTMI RSS Generator https://www.taxtmi.com/notifications?id=140236 Exempts specified pharmaceutical goods from state tax in excess of the rates specified in the notification, referencing tariff items in the First Schedule to the Customs Tariff Act; Tocilizumab and Amphotericin B are subject to nil state tax, while Remdesivir, Heparin, Itolizumab, Posaconazole, Infliximab, Bamlanivimab & Etesevimab, Casirivimab & Imdevimab, 2 Deoxy D Glucose and Favipiravir are subject to a reduced state tax rate; the exemption operates for the temporary period from October through December 2021. Notifications GST - States Sat, 05 Mar 2022 00:00:00 +0530 https://www.taxtmi.com/notifications?id=140236